The Aperlena Verdict
Open raceNo supplier dominates: 4 different companies have won the last 4 comparable contracts from this buyer over 5 years. This is a genuinely open race.
Based on 4 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryThis call for tenders seeks to speed up development of promising Next Generation Therapeutics for Infectious Diseases through phased, competitive development under a Pre-Commercial Procurement (PCP) approach, awarded via multiple sourcing framework contracts. Scope covers innovative therapeutics for viral infections, ARDS or sepsis, including pathogen-targeted and host-targeted therapeutics, combination therapies and alternative routes to IV, excluding small molecules and monoclonal antibodies. Lot 1 covers pathogen-targeted therapeutics; Lot 2 covers host-targeted therapeutics. The buyer is located in Belgium. Estimated value and deadline are not stated. Suppliers of R&D and related consultancy services in this field may bid under the described procedure.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profile5 open tenders right now
- Belgium - Research and experimental development services - Long-term API stockpiling and rapid finished dose form manufacture 14 days left
- Belgium - Storage and warehousing services - Capacity Reservation for Personal Protective Equipment Pilot 30 days left
- Belgium - Training services - Harmonising the implementation of EU legal requirements in the fields of Plant Health and Plant Protection Products through the 'Better Training for Safer Food' Initiative 34 days left
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| PREDICTBY RESEARCH AND CONSULTING S.L.; EUROPEAN BLOOD ALLIANCE; EEBA; ESHRE; EUROPEAN HEMATOLOGY ASSOCIATION; EUROPEAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION; EHMSG; European Association of Tissue and Cell Banks, EATCB; EMBA | 1 | €3.5M | Mar 2026 |
| VERIAN GROUP BELGIUM | 1 | €900,250 | Jan 2026 |
| AGENCE DE LA BIOMEDECINE | 1 | n/a | Feb 2026 |
| NIVI Development P/S; ETHRIS; SSI; VISMEDERI SRL; ECRAID; BAVARIAN NORDIC; EVO; IDT; SANOFI R&D VACCINS; SVA | 1 | n/a | Dec 2025 |
Based on 4 awards with a linked company profile over the last 5 years.
Change history
Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.
-
Read before bidding
- Title: "Belgium - Research and development services and related consultancy services - M..." to "Belgium – Research and development services and related consultancy services – M..."
- Estimated value: Set to €252,000,000
- Scope and criteria: The description was expanded. Re-read it before you bid.
- Estimated value: Set to €252,000,000
Follow this tender and we email you the moment it changes. Create account
Similar tenders
3
days left
€2,000,000
est. value
14
days left
€6,000,000
est. value
Market context
- Avg. open tender · Research & development
- €3,390,052
- Buyer track record on Aperlena
- 27 notices tracked · 9 awarded
- €17,719,420 in awarded contracts
Never miss a tender like this
5 new notices in Research & development in Belgium in the last 7 days. Get an email when new ones appear. Free.
Set up my alert